SCHEMBL31350180

SCHEMBL31350180

CC1(C)O[C@H]2[C@H](n3cnc4c(N[C@@H](C5CCC5)C5CC5)nc(I)nc43)[C@H]3C[C@@]3(CO[Si](c3ccccc3)(c3ccccc3)C(C)(C)C)[C@H]2O1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HTR2B P41595 17/20 0.53
▸ HTR2C P28335 16/20 0.53
▸ ADORA1 P30542 15/20 0.53
▸ HRH1 P35367 1/20 0.53
▸ ADORA3 P0DMS8 9/20 0.52
▸ TSPO P30536 3/20 0.52
▸ HRH2 P25021 2/20 0.49
▸ HTR5A P47898 1/20 0.49
▸ TMIGD3 P0DMS9 2/20 0.45
▸ ADORA2A P29274 2/20 0.45
▸ SLC6A3 Q01959 3/20 0.43
▸ TMEM97 Q5BJF2 2/20 0.43
▸ CHRM3 P20309 1/20 0.43
▸ ADRA2C P18825 1/20 0.42
▸ HTR1D P28221 1/20 0.42
▸ HTR2A P28223 1/20 0.42
▸ OPRM1 P35372 1/20 0.42
▸ ADRB3 P13945 1/20 0.42
▸ ADRA2B P18089 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31350142 1.00 HTR2B (0.53) HTR2BHTR2CADORA1HRH1ADORA3
SCHEMBL31350082 0.99 ADORA1 (0.52) HTR2BHTR2CADORA1HRH1ADORA3
SCHEMBL31350227 0.98 HTR2B (0.51) HTR2BHTR2CADORA1HRH1ADORA3
SCHEMBL31350206 0.91 HRH2 (0.57) HTR2BHTR2CADORA1ADORA3TSPO
SCHEMBL31350157 0.90 HRH2 (0.56) HTR2BHTR2CADORA1ADORA3TSPO
SCHEMBL31350114 0.84 HRH2 (0.44) HTR2BHTR2CADORA1ADORA3TSPO
SCHEMBL31350143 0.84 ADORA3 (0.38) HTR2BHTR2CADORA1HRH1ADORA3
SCHEMBL31350236 0.82 HTR2B (0.70) HTR2BHTR2CADORA1HRH1ADORA3
SCHEMBL31350238 0.80 HTR2B (0.71) HTR2BHTR2CADORA1HRH1ADORA3
SCHEMBL31350170 0.78 HRH2 (0.43) HTR2BHTR2CADORA1ADORA3HRH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4747254-A1 <SUP2/>? <SUB2/>?2B?5-HTSEROTONIN RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE THEREOF The United States of America, as represented by the Secretary, Department of Health and Human Services (US) 2026-05-27 — — EP disclosed
WO-2025019529-A1 5-HT 2B SEROTONIN RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE THEREOF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2025-01-23 — — WO disclosed
Send feedback